Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ToTem: CD62L- Effector Memory T Cells After Stem Cell Transplant
NCT03836690Phase 1Unknown
- Sponsor
- University College London
- Start
- Oct 2019
- Primary completion
- Jul 2022
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of CD62L-depleted effector memory T cells in graft-versus-host disease (GVHD) and Infection, sponsored by University College London. Status: unknown.
02
Drugs
CD62L-depleted effector memory T cells
03
Conditions
graft-versus-host disease (GVHD)Infection
Beyond the preview
Go deeper on NCT03836690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03836690.